Medication Risk Mitigation System and Method

Tabula, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 61/920,052, filed Dec 23, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 10,720,241	Medication Risk Mitigation System and Method Tabula Rasa Healthcare Group, Inc. In force Term ends Oct 16, 2035 · High confidence	Tabula Rasa Healthcare Group, Inc.	In force	Term ends Oct 16, 2035	Term ends Oct 16, 2035	High confidence
US 11,862,343	Medication Risk Mitigation System and Method Tabula Rasa Healthcare Group, Inc. In force Term ends Oct 16, 2035 · High confidence	Tabula Rasa Healthcare Group, Inc.	In force	Term ends Oct 16, 2035	Term ends Oct 16, 2035	High confidence
Application 18/398,406	Medication Risk Mitigation System and Method Tabula Rasa Healthcare Group, Inc. Pending Not granted	Tabula Rasa Healthcare Group, Inc.	Pending	Not granted	not computed

3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

2 of these are in force and held by Tabula, Inc..

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.